Regeneron Hires Firm to Market Former Avon R&D Facility in Suffern for Sale or Lease
Regeneron Pharmaceuticals abandoned plans last November to spend $139 million to renovate the former Avon Products facility it had acquired in December 2023 for $38,875,000 from Avon Capital Corp.
Sponsors of the RPAC Happy Hour at Pax Romana.
From left, Ron Garafalo and Rich Herska, HGAR RPAC
From left, Nan Palumbo and Crystal Hawkins-Syska,
Anthony Morreale and Sandra Salguero
A large crowd of HGAR Realtors filled the bar area at Pax Romana.